داروسازی فارابی
دفارا | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 19,980 2.99
Close Price: 19,930
Balance Sheet
AGM
Interim
2026/07/21 Fiscal Year 2026/03/2012 Month | 2025/05/27 Fiscal Year 2025/03/2012 Month | 2024/05/27 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 899.795 Billion | 479.833 Billion | 1.39 Trillion | |
Short-Term Investments | 15.804 Billion | 11.183 Billion | 8.488 Billion | |
Trade Receivables | 35.062 Trillion | 27.739 Trillion | 18.144 Trillion | |
Prepayments | 1.381 Trillion | 2.519 Trillion | 1.956 Trillion | |
Raw Materials & Packaging Inventory | 6.503 Trillion | 3.926 Trillion | 6.035 Trillion | |
Work-in-Progress Inventory | 1.014 Trillion | - | - | |
Finished Goods Inventory | 582.44 Billion | 892.037 Billion | 1.12 Trillion | |
Spare Parts Inventory | 192.431 Billion | 120.281 Billion | 101.404 Billion | |
Our Goods on Consignment with Others | 65.217 Billion | 53.208 Billion | 33.287 Billion | |
Other Inventories | 14.746 Billion | 65 Million | 13.76 Billion | |
Inventories | 8.372 Trillion | 4.991 Trillion | 7.304 Trillion | |
Total Current Assets | 45.731 Trillion | 35.74 Trillion | 28.802 Trillion | |
Long-Term Investments | 1.819 Billion | 1.819 Billion | 1.693 Billion | |
Long-Term Investments in Affiliates | 509.535 Billion | 509.535 Billion | 527.281 Billion | |
Long-Term Trade Receivables | 37.913 Billion | 23.803 Billion | 26.529 Billion | |
Intangible Assets | 17.447 Billion | 27.687 Billion | 18.892 Billion | |
Other Assets | 961.373 Billion | 979.355 Billion | 970.696 Billion | |
Property, Plant & Equipment | 5.536 Trillion | 5.486 Trillion | 924.73 Billion | |
Net Fixed Assets | 5.536 Trillion | 5.486 Trillion | 924.73 Billion | |
Total Non-Current Assets | 7.064 Trillion | 7.028 Trillion | 2.47 Trillion | |
Total Assets | 52.795 Trillion | 42.768 Trillion | 31.272 Trillion | |
Trade Payables | 7.222 Trillion | 9.733 Trillion | 8.323 Trillion | |
Advances Received | - | 1.389 Billion | 27.376 Billion | |
Income Tax Provision | 2.473 Trillion | 1.233 Trillion | 1.442 Trillion | |
Proposed & Payable Dividends | 10.943 Trillion | 8.086 Trillion | 4.098 Trillion | |
Current Borrowings | 5.454 Trillion | 4.639 Trillion | 6.565 Trillion | |
Total Current Liabilities | 26.092 Trillion | 23.693 Trillion | 20.456 Trillion | |
Long-Term Payables | 236.158 Billion | 162.26 Billion | 94.663 Billion | |
Employee Termination Benefits Provision | 683.772 Billion | 452.536 Billion | 337.766 Billion | |
Total Non-Current Liabilities | 919.93 Billion | 614.796 Billion | 432.429 Billion | |
Total Liabilities | 27.012 Trillion | 24.308 Trillion | 20.888 Trillion | |
Capital | 9.206 Trillion | 1.6 Trillion | 1.6 Trillion | |
Retained Earnings | 15.757 Trillion | 12.294 Trillion | 8.724 Trillion | |
Legal Reserve | 920.6 Billion | 160 Billion | 160 Billion | |
Share Premium Reserve | -100.384 Billion | -100.384 Billion | -100.384 Billion | |
Total Equity | 25.783 Trillion | 18.459 Trillion | 10.384 Trillion | |
Total Liabilities & Equity | 52.795 Trillion | 42.768 Trillion | 31.272 Trillion | |
Approved Capital | 9.206 Trillion | 1.6 Trillion | 1.6 Trillion | |
Approved Retained Earnings | 7.195 Trillion | 3.694 Trillion | 3.124 Trillion | |
Approved Legal Reserve | 920.6 Billion | 160 Billion | 160 Billion | |
Total Approved Equity (at AGM) | 17.322 Trillion | 5.454 Trillion | 4.884 Trillion | |
Revaluation Surplus of Property, Plant and Equipment | - | 4.506 Trillion | - |